Literature DB >> 8423829

Duration of amyotrophic lateral sclerosis is age dependent.

A Eisen1, M Schulzer, M MacNeil, B Pant, E Mak.   

Abstract

Since 1985, we prospectively followed 246 patients with ALS. The relationship between the age of developing neurological impairment and disease duration was analyzed in 138 patients (86 men and 52 women) who died. Mean disease duration was 4.0 +/- 3.8 years for men and 3.2 +/- 2.5 years for women. There was an inverse, exponential, relationship between onset age and duration (goodness-of-fit P > 0.05). Mean duration at onset age < or = 40 years was 8.2 +/- 5.0 years compared with 2.6 +/- 1.4 years for patients aged 61 to 70 years (P > 0.001). The ratio of young (< or = 40 years) men to women was 3.6:1. When matched for age, disease duration was the same for patients with bulbar and nonbulbar onsets. We conclude that onset age, but not sex, is the most significant predictor determining disease duration in ALS. Longer survival in younger patients probably reflects their greater neuronal reserve.

Entities:  

Mesh:

Year:  1993        PMID: 8423829     DOI: 10.1002/mus.880160107

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  20 in total

Review 1.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

2.  Amyotrophic Lateral Sclerosis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

3.  Motoneuron afterhyperpolarisation duration in amyotrophic lateral sclerosis.

Authors:  Maria Piotrkiewicz; Irena Hausmanowa-Petrusewicz
Journal:  J Physiol       Date:  2011-03-28       Impact factor: 5.182

4.  Synaptophysin in spinal anterior horn in aging and ALS: an immunohistological study.

Authors:  F F Cruz-Sánchez; A Moral; M L Rossi; L Quintó; C Castejón; E Tolosa; J de Belleroche
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

5.  The effect of autologous bone marrow mononuclear cell transplantation on the survival duration in Amyotrophic Lateral Sclerosis - a retrospective controlled study.

Authors:  Alok K Sharma; Hemangi M Sane; Amruta A Paranjape; Nandini Gokulchandran; Anjana Nagrajan; Myola D'sa; Prerna B Badhe
Journal:  Am J Stem Cells       Date:  2015-03-15

6.  Amyotrophic lateral sclerosis: early predictors of prolonged survival.

Authors:  Adam Czaplinski; Albert A Yen; Stanley H Appel
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

7.  Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis.

Authors:  R P Bruyn; J H Koelman; D Troost; J M de Jong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

Review 8.  Physical activity and neuroprotection in amyotrophic lateral sclerosis.

Authors:  Mary E McCrate; Brian K Kaspar
Journal:  Neuromolecular Med       Date:  2008-02-20       Impact factor: 3.843

9.  Diagnostic accuracy using diffusion tensor imaging in the diagnosis of ALS: a meta-analysis.

Authors:  Bradley R Foerster; Ben A Dwamena; Myria Petrou; Ruth C Carlos; Brian C Callaghan; Martin G Pomper
Journal:  Acad Radiol       Date:  2012-06-28       Impact factor: 3.173

Review 10.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.